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SUMMARY 
Background: Diabetes mellitus continues to present a major medical challenge despite the 
array of antidiabetic medicines on the market. The disorder is characterized by chronic 
hyperglycaemia and glycosuria. This study aims to study the hypoglycaemic potential of 
the aqueous extract of Allanblackia floribunda leaves in alloxan-induced diabetic rats.   
Methods: In the study, 25 albino rats weighing between 180-200 g were divided into five 
groups of five animals each. Group 1 contained normal untreated rats, group 2 contained 
diabetic untreated rats, group 3 & 4 were diabetic rats treated with 50 and 25 mg/kg of the  
aqueous extract of A. floribunda leaves respectively and group 5 contained diabetic rats 
treated with 0.5mg/kg glibenclamide for 15 days. Animals for the hypoglycaemic study 
were treated for two weeks post induction. Fasting blood glucose (FBG) levels were 
determined using the glucose oxidase method. FBG of the experimental animals were 
significantly reduced by A. floribunda.  
Results: A 72.5%  and 62.8% reduction in glucose level was observed for 50 mg/kg  and 
25 mg/kg dose of A. floribunda while a 71.8% reduction was noted for 0.5 mg/kg 
glibenclamide. Hence, 50 mg/kg dose of the aqueous extract was as potent as 0.5 mg/kg 
glibenclamide in inducing hypoglycaemia. Pre-treatment of the animals with the extracts 
for two weeks resulted in a significant lowering of the fasting blood glucose level of the 
animals pre-incubation and significantly reduced the effect of alloxan on FBG levels of the 
animals. Phytochemical screening of the aqueous leaf extract revealed the presence of 
tannins, flavonoids, terpenoids, saponins, cardiac glycosides, alkaloids, steroids and 
anthraquinones.  
Conclusion: This study has demonstrated the potential of the aqueous extract of A. 
floribunda as both a hypoglycaemic agent and suggests that the extract may have a 
protective effect against the development of  diabetes.  
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1. Introduction 
Diabetes mellitus is a disease characterized 
by chronic hyperglycaemia and glucosuria  
produced by an absolute or relative insufficiency 
of insulin. The ailment may result into the 
development of further metabolic and anatomic 
disturbances among which is lipemia, 
hypercholesterelaemia, loss of weight, ketosis, 
arteriosclerosis, gangrene, pathologic changes in 
the eye, neuropathy, renal disease and coma.  
Hyperglycaemia and glucose intolerance are 
common manifestations of several types of 
hormonal disturbances or imbalances, of which 
the most important is diabetes mellitus. The 
World Health Organization (WHO) estimates 
that more than 180 million people worldwide 
have diabetes. In 2005, an estimated 1.1 million 
people died from diabetes [1]. Hence despite the 
presence of various antidiabetic medicine on the 
market, diabetes and related complications 
continues to be a major medical problem.  
Urgent breakthroughs are needed in combating 
this disease. 
The search for a cure for diabetes mellitus 
continues along with traditional and alternative 
medicine. Many herbal supplements have been 
used for the treatment of diabetes, but not all of 
them have scientific evidence to support their 
effectiveness [2]. 
Allanblackia floribunda is an evergreen tree 
found in the rainforest.  Its traditional uses 
indicate possible anti-inflammatory and 
antimicrobial activities [3,4]. Recently, we have 
reported the free-radical scavenging activity and 
anti-inflammatory property of Allanblackia 
floribunda [5,6]. Implications of free-radicals in 
the pathogenesis of diabetes has prompted us to 
investigate the possible hypoglycaemic effect of 
this plant [7,8]. Hypoglycaemic effect of A. 
floribunda in alloxan- induced diabetic rats is 
hereby reported. 
2. Materials and Methods 
Collection and extraction of Plant sample 
Allanblackia floribunda leaves were collected 
fresh from forest sources in Oke-igbo, Ondo State, 
South-West Nigeria in March 2008 by Professor 
TO Odugbemi. The leaves were identified at the 
Forestry Research Institute of Nigeria (FRIN), 
and given a voucher number ((FHI107929). The 
leaves were air dried in the oven for 3 days at a 
temperature of 38oC and milled. The powdered 
leaves (300 g each) were soaked in 120 ml of 
distilled water for 24 h. The crude extract was 
filtered first through cotton wool, then through 
Whatman filter paper No 42 (125 mm).  The 
extract collected was freeze-dried and stored 
refridgerated in a glass bottle until ready for use. 
Phytochemical screening was performed 
using standard procedures [9,10].  
Animals  
 Healthy adult male Sprague Dawley rats, 
weighing between 180-200 g were used in the 
present study. The animals were housed in clean 
cages and maintained in a well-ventilated animal 
house, under 12 h light and dark. The animals 
were fed with standard rat pellet diet (Livestock 
Nigeria Ltd.) and tap water was made available 
ad  libitum. Animals were fasted before the start 
of the experiment. The study was carried out in 
accordance with the internationally accepted 
principles for laboratory animal use and care.  
Ethical approval was granted by the College of 
Medicine, University of Lagos, Nigeria. 
Experimental design 
Induction of diabetes 
Rats were fasted overnight before induction 
of diabetes with alloxan. The rats were given an 
intraperitoneal injection of alloxan (160 mg/kg). 
Preliminary determination of the dose of alloxan 
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used was carried out by first treating the 
experimenatal animals with the usual 120 
mg/kg dose of alloxan which was found to only 
induce diabetes in 20% of the rats induced after 
48 h. Alloxan dose of 140 mg/kg induced 
diabetes in 50% population of rats used, while 
160 mg/kg dose induced diabetes in 90% of the 
rats induced after 48 h. Diabetic rats used for the 
study were selected from the 160 mg/kg dose 
alloxan-treated rats. Animals with blood glucose 
level ≥250 mg/dl were included in the study. 
Blood Sampling and Biochemical Estimation 
Blood glucose level was monitored after 
alloxan treatment to confirm the diabetic state. 
Diabetes state was confirmed in the rats using 
glucose oxidase method using analytic kit 
purchased from Randox U.K.  Blood samples for 
the glucose analysis were collected from the 
animals into Lithium oxalate bottles from the 
retro-orbital sinus using heparinised capillary 
tubes. 
Effect of the aqueous extract of A. floribunda on 
the fasting blood glucose (FBG) levels in 
alloxan-induced diabetic rats 
Control and diabetic rats were weighed,  and 
divided into the following groups of five rats 
each 
Group I (Normal Control group): They 
received rat feed and tap water ad libitum 
throughout the period of the experiment 
Group II (Diabetic Control): The diabetic rats 
received equal volume of distilled water orally 
throughout the period of the experiment along 
with tap water and feed ad libitum.  
Group III (Extract treated group 50 mg/kg): 
The diabetic rats were administered 50 mg/kg 
body weight of the aqueous leaf extract of 
Allablackia floribunda orally using oral dosing 
needle for 15 days. 
Group IV (Extract treated group 25 mg/kg) :  
The diabetic rats in this group were administered 
25 mg/kg body weight of the aqueous leaf 
extract of Allablackia floribunda orally using oral 
dosing needle for 15 days. 
Group V (Reference drug group): The 
diabetic rats were administered a standard 
hypoglycaemic drug Glibenclamide obtained 
from May & Baker Nigeria Ltd. at a dose of 
0.5mg/kg body weight for 15 days. 
Effect of pre-treatment with the aqueous extract 
of Allanblackia floribunda on  alloxan-induced 
diabetes (prohylactic study) 
The animals for the prophylactic study were 
divided into 3 groups as follows; 
Group 1: They received rat feed and tap 
water ad libitum throughout the period of the 
experiment 
Group 2: The rats in this group treated with 
aqueous solution of extract Allanblackia floribunda 
leaves at a dose of 50 mg kg-1 body weight per 
day for 14 days before treatment with 160 mg/kg 
alloxan. 
Group 3:  The rats were treated with aqueous 
solution of extract Allanblackia floribunda leaves at 
a dose of 25 mg kg-1 body weight per day 
All animals in the prophylaxis groups were 
treated with 160 mg/kg of alloxan after two 
weeks treatement with extract (Group 2 & 3) or 
water (Group 1). 
Acute toxicity test 
Thirty Swiss albino mice were divided into 
five goups. The extract was reconstituted in 
normal saline and administered orally as a single 
dose to groups at different concentrations (2, 4, 8, 
16 and 32 g/kg). The animals were observed for 
a period of 48 h.  The number of deaths recorded 
was expressed as a percentile and the LD50 was 
determined by probit test using the death 
percentage versus the log dose [11]. 
Statistical analysis 
All data were analysed using one-way 
ANOVA and results presented as mean ±SEM. 
Level of significance was placed at P value  ≤ 0.05. 
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3. Results and Discussion 
Preliminary phytochemical screening of the 
extract revealed the presence of tannins, 
flavonoids, terpenoids, saponins, cardiac 
glycosides, alkaloids, steroids and 
anthraquinones (Table 1).  
There was a significant elevation in the blood 
glucose level by approximately 3 times after 
administration of alloxan when compared to 
normal rats.  Administration of 25 mg/kg of the 
aqueous extract of A. floribunda caused a 
significant and constistent reduction in the blood 
glucose levels of diabetic rats from day 6 
onwards in a dose dependent manner.  Fifty 
mg/kg dose of the extract was found to be as 
effective as 0.5 mg/kg glibenclamide in 
reduction of blood glucose levels in the diabetic 
rats (Figure 1 & Table 2).  
Table 1:  Phytochemical Constituents of A. 
floribunda leaves 
Phytochemical 
Tests 
floribunda 
leaves 
Alkaloids + 
Anthraquinones + 
Cardiac 
glycosides 
+ 
Flavonoids + 
Phlobatannins - 
Saponins + 
Steroids + 
Tannins + 
Terpenoids + 
 
Glibenclamide is a conventional antidiabetic 
agent that is widely used in the treatment of type 
2 diabetes. A 72.5 and 71.8% reduction in blood 
glucose levels were observed for 50 mg/kg 
extract and 0.5 mg/kg glibenclamide 
respectively, whereas a 62.8% decrease was 
recorded for 25 mg/kg dose of the extract. The 
blood glucose level with 50 mg/kg of extract and 
0.5 mg/kg glibenclamide was comparable to the 
levels in the normal untreated rats by day 15.  
However, the glucose level in the rats treated 
with 25 mg/kg dose were still slightly higher 
(97.6 mg/dl) compared to those of the normal 
untreated rats at day 15.  There was a very great 
increase in blood glucose levels in the untreated 
diabetic rats (from 260.2 mg/dl 48 h post-
induction  to 450.0 mg/dl, 6 days post-induction) 
which resulted in death after 6 days (Figure 1 & 
Table 2). There was no significant change in the 
blood glucose levels of the control rats.  A 
significant reduction in blood glucose levels of 
rats treated with the aqueous extracts pre-
induction was observed (Table 3).  Furthemore, 
pre-treatement of rats with the aqueous extracts 
prior to induction significantly reduced the 
blood glucose levels of rats post- induction 
compared to rats that were not pre-treated with 
the aqueous extract of A. floribunda (Table 3). 
Alloxan induces diabetes through its ability 
to destroy the insulin secreting pancreatic β-cells 
resulting in a decrease in endogenous insulin 
release [8,12]. In vitro studies have shown that 
alloxan is selectively toxic to pancreatic beta cells, 
leading to the induction of cell necrosis [13].  The 
cytotoxic action of alloxan is mediated by 
reactive oxygen species with a simultaneous 
massive increase in cytosolic calcium 
concentration, leading to a rapid destruction of 
beta cells [14]. Hyperglycemia increases the 
generation of free radicals by glucose auto-
oxidation and the increment of free radicals may 
lead to liver cell damage.   
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Table 2:  Percentage reduction in fasting blood glucose level (FBG) in rats treated orally with aqueous extract of 
Allablackia floribunda for 15 days compared with non-diabetic control, and diabetic untreated and diabetic rats 
treated with glibenclamide rats 
Group 
Percentage reduction in fasting glucose level 
Duration (Days) 
3 6 9 12 15 
Normal (Group 1) 0.00 0.82 -0.82 0.00 0.00 
Diabetic control (Group2) *-53.96a *-73.02a ** ** ** 
Diabetic+50mg/kg extract 
(Group 3) 20.08c,d 40.98a,c,d 60.15a,c,d 67.22a,c,d 72.56a,b,d 
Diabetic + 25 mg/kg extract 
(Group 4) 9.24b,c,d 28.02a,b,c,d 43.05a,b,c,d 57.41a,b,c,d 62.75a,b,c,d 
Diabetic + glibenclamide 
0.5mg/kg (Group5) 12.91 30.15a,d 60.52a,d 68.36a,d 71.79a,d 
 Mean value of 5 animals per group.  a= P ≤0.05 compared to the initial value, b = P ≤0.05 compared FBG for 
Group 3, c = P≤0.05 compared with Group 5, d =P≤0.05 compared with control (Group 1) , *increase in PBG 
observed with untreated diabetic rats, **death occured in animals in the untreated diabetic group.  The negative 
sign indicates an increase in blood glucose level compare to the previous. 
 
Table 3:  Percentage increase in fasting blood glucose level in rats pretreated orally with aqueous extract of 
Allanblackia floribunda for 2 weeks before induction of diabetes with alloxan compared with rats without 
extract administration. 
Treatment FBG before treatment 
(initial-mg/dl)  
 
FBG after 
treatment with 
extract for 2 
weeks (mg/dl) 
FBG 2 days after 
treatment with alloxan 
160 mg/kg (mg/dl) (A) 
% increase FBG 
after alloxan 
treatmentcompar
ed to initial FBG  
Normal (Group 1) 73.6 ± 2.4  NT 260.2 ± 6.5a 71.7 
Extract (50 mg/kg – 
Group 2) 
73.5 ± 2.7 
 45.5 ± 1.7a 144.5 ± 6.5a,b 49.1  
Extract (25 mg/kg 
Group 3) 
75.3 ± 2.0 
 65.3 ± 1.9a 193 ± 2.6a,b 61.0  
 
Mean value  of  5 animals per group.  a= P≤0.05 compared to initial, b = P≤0.05 compared to normal control 
(Group 1).  NT = Animals  not treated with extract pre-induction of diabetes. The negative sign indicates a 
decrease in blood glucose level compare to the 
previous. 
 
We have previously shown that A. 
floribunda possesses potent free-radical 
scavenging activity [5]. This may well be one of 
the mechanism of action of A. floribunda.  
Presence of antioxidant molecules such as 
flavonoids, tannins (shown in phytochemical 
screening experiments) in the extract may be one 
of the factors responsible for the observed 
hypoglycaemic effect of the extract [15].  
Conclusion 
The study has demonstrated that the aqueous 
extract of A. floribunda significantly reduced blood 
glucose levels in alloxan-induced diabetic rats and 
the effect of 50 mg/kg dose was comparable to that 
of 0.5 mg/kg glibenclamide. It was also able to 
prevent mortality in the diabetic rats. Furthermore, 
pre-treatment of the rats with the aqueous extract 
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prior to induction of diabetes, reduced the effect of 
alloxan on the blood glucose levels. This would 
suggest a protective effect on the pancreatic β-cells 
possibly by the free radical scavenging effect of the 
plant extracts. Furtherwork is now in progress 
regarding the phtyochemical(s) responsible for the 
hypoglycaemic effect of A. floribunda and its 
mechanism of action. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Graph of Plasma blood glucose level 
against duration of treatment. Graph shows 
reduction of fasting blood glucose in alloxan-
induced diabetic rats by the aqueous extract of 
Allanblackia floribunda at 50 mg/kg and 25mg/kg 
doses.  Activity at 50 mg/kg dose was comparable 
to that of 0.5 mg/kg glibenclamide. 
LD50 for the aqueous extract of Allanblackia 
floribunda was determined as 9.5 g/kg.  This 
suggests that the extract is relatively safe. 
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